CD274 and melanoma: Johnson and colleagues previously described a higher PD-1/PD-L1 interaction score to be predictive for response to immunotherapy, not considering the underlying type of cell-cell interaction or the cell types expressing these markers and independent of HLA-DR expression by the melanoma cells (14).